Clinically relevant differences between the statins: implications for therapeutic selection
- 1 October 2001
- journal article
- research article
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 111 (5), 390-400
- https://doi.org/10.1016/s0002-9343(01)00870-1
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysisClinical Therapeutics, 2001
- Randomized Comparison of the Efficacy and Safety of Cerivastatin and Pravastatin in 1030 Hypercholesterolemic PatientsMayo Clinic Proceedings, 2000
- Statins: Effective antiatherosclerotic therapyAmerican Heart Journal, 2000
- Efficacy and Safety of Cerivastatin 0.8 mg in Patients with Hypercholesterolaemia: The Pivotal Placebo-Controlled Clinical TrialJournal of International Medical Research, 2000
- The evolving role of statins in the management of atherosclerosisJournal of the American College of Cardiology, 1999
- Drug Treatment of Lipid DisordersNew England Journal of Medicine, 1999
- Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemiaThe American Journal of Cardiology, 1999
- Natural Statins and Stroke RiskCirculation, 1999
- Cerivastatin in primary hyperlipidemia: a multicenter analysis of efficacy and safetyThe American Journal of Cardiology, 1998
- Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.The American Journal of Cardiology, 1998